Swedish Cancer Institute - Issaquah Campus — Issaquah, Washington

Swedish Cancer Institute - Issaquah Campus is a clinical research site located in Issaquah, Washington, United States 98029.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Swedish Cancer Institute - Issaquah Campus has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, Melanoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Swedish Cancer Institute - Issaquah Campus?

Swedish Cancer Institute - Issaquah Campus has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Swedish Cancer Institute - Issaquah Campus conducted?

Swedish Cancer Institute - Issaquah Campus has 2 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, Melanoma.

Is Swedish Cancer Institute - Issaquah Campus accredited by Crixeo Health?

Swedish Cancer Institute - Issaquah Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Swedish Cancer Institute - Issaquah Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.